Search results for "Optimal treatment"

showing 10 items of 10 documents

THE OPTIMIZATION OF INTERFERON FOR MS STUDY: 375 MICROG INTERFERON BETA-1B IN SUBOPTIMAL RESPONDERS.

2008

We aimed to evaluate the safety and MRI efficacy of interferon beta-1b (IFNbeta-1b) 375 microg (subcutaneously [sc] every other day [eod]) in relapsing-remitting multiple sclerosis (RRMS) patients with a suboptimal response to IFNbeta-1b 250 microg, i.e., with MRI activity or relapses. The OPTimization of Interferon for MS (OPTIMS) study was a prospective multicenter randomized phase 2 trial comprising a 6-month run-in phase (to identify suboptimal responders) and a 6-month randomized phase of open-label clinical and blinded MRI follow-up. During run-in all patients were treated with IFNbeta-1b 250 microg sc eod; during the study phase suboptimal treatment responders were randomized either …

Adultmedicine.medical_specialtyTime FactorsAdolescentInjections Subcutaneoussuboptimal treatment responseGastroenterologyDrug Administration Schedulelaw.inventionYoung AdultMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesAdverse effectProspective cohort studyinterferon beta (IFNβ)immunomodulatory drugSubclinical infectionDose-Response Relationship Drugbusiness.industryInterferon beta-1bInterferon-betaMiddle AgedMagnetic Resonance ImagingConfidence intervalSurgeryClinical trialTreatment OutcomeNeurologyRelative riskmultiple sclerosiMRI activitySettore MED/26 - NeurologiaNeurology (clinical)businessFollow-Up StudiesInterferon beta-1b
researchProduct

Electrocoagulation treatment of peat bog drainage water containing humic substances

2015

Abstract Electrocoagulation (EC) treatment of 100 mg/L synthetic wastewater (SWW) containing humic acids was optimized (achieving 90% CODMn and 80% DOC removal efficiencies), after which real peat bog drainage waters (PBDWs) from three northern Finnish peat bogs were also treated. High pollutant removal efficiencies were achieved: Ptot, TS, and color could be removed completely, while Ntot, CODMn, and DOC/TOC removal efficiencies were in the range of 33–41%, 75–90%, and 62–75%, respectively. Al and Fe performed similarly as the anode material. Large scale experiments (1 m3) using cold (T = 10–11 °C) PBDWs were also conducted successfully, with optimal treatment times of 60–120 min (applying…

Environmental EngineeringPeatmedicine.medical_treatmentColorIndustrial WasteWastewaterWaste Disposal FluidElectrolysisElectrocoagulationWater PurificationSoilmedicineDrainageOperational costsWaste Management and DisposalBogFinlandHumic SubstancesWater Science and TechnologyCivil and Structural EngineeringBiological Oxygen Demand AnalysisPollutantgeographygeography.geographical_feature_categoryChemistryEcological ModelingOptimal treatmentEnvironmental engineeringPollutionWastewaterEnvironmental chemistryWater Pollutants ChemicalWater Research
researchProduct

Optimal decongestive therapy in acute decompensated heart failure syndromes: Far from being solved

2014

We have read with great interest the article entitled “Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) Trial” [1]. First, we would like to commend the authors for their effort in carrying out this investigator-initiated clinical trial by testing the prognostic effect of three decongestive strategies in the management of patients with acute decompensated heart failure (ADHF). The analysis of the data revealed no-significant differences in the in-hospital and post-discharge outcomes between high (HDF) vs low-dose furosemide infusion (LDFD); the addition of low-dose dopamine infusion…

Malemedicine.medical_specialtyCardiotonic AgentsAcute decompensated heart failuremedicine.drug_classDopamineFurosemideDopamineInternal medicinemedicineHumansDiureticsBeneficial effectsHeart Failurebusiness.industryOptimal treatmentLow doseFurosemideLoop diureticmedicine.diseaseClinical trialCardiologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational Journal of Cardiology
researchProduct

What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort

2021

International audience; Introduction: for localized T1N0 squamous cell carcinoma of the anus (SCCA) standard radiotherapy (RT) may result in overtreatment and alternative strategies are debated. Methods: T1N0M0 SCCA treated between 2015 and 2020 by local excision (LE) or RT were analyzed from the French prospective FFCD ANABASE cohort. Treatment strategies, recurrence-free and colostomy-free survivals (RFS, CFS) and prognostic factors were reported. Results: among 1135 SCCA patients, 99 T1N0M0 were treated by LE(n = 17,17.2%), or RT ( n = 82,82.8%) including RT alone ( n = 65,79.2%) or chemo-RT ( n = 17, 20.7%). Median follow-up was 27.2 months [0.03 and ndash;54.44]. Median tumor size were…

Malemedicine.medical_specialtyLocal excisionLocal excisionmedicine.medical_treatmentAnal Canal[SDV.CAN]Life Sciences [q-bio]/CancerGastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineAgedRetrospective StudiesAged 80 and overUnivariate analysisHepatologyRadiotherapybusiness.industryOptimal treatmentGastroenterologyAnal Squamous Cell CarcinomaChemoradiotherapyMiddle AgedAnusAnus Neoplasms3. Good healthRadiation therapymedicine.anatomical_structureAnal canal carcinoma030220 oncology & carcinogenesisCohortCarcinoma Squamous CellFemaleFrancebusinessChemoradiotherapy
researchProduct

Fragility Fractures of the Pelvis.

2017

Fragility fractures of the pelvic ring (FFP) show an increasing frequency. Trauma mechanism, fracture morphology and degree of instability are different from those in high-energy pelvic ring lesions. Little is known about the optimal treatment strategy. A new comprehensive classification system with four categories of increasing instability is presented. It is connected with recommendations for type and invasiveness of treatment. FFP Type I are anterior instabilities only and can be treated conservatively. FFP Type II are non-displaced posterior lesions which can be treated conservatively or with percutaneous fixation. FFP Type III lesions are unilateral displaced posterior lesions which re…

Malemedicine.medical_specialtymedicine.medical_treatmentFrail Elderly03 medical and health sciencesFractures Bone0302 clinical medicinePelvic ringFracture FixationmedicineInsufficiency fractureInternal fixationHumansOrthopedics and Sports MedicinePelvic BonesReduction (orthopedic surgery)PelvisFixation (histology)AgedAged 80 and over030222 orthopedicsFrailtybusiness.industryOptimal treatment030208 emergency & critical care medicineSurgerymedicine.anatomical_structurePercutaneous fixationSurgeryFemalebusinessJBJS reviews
researchProduct

Optimal treatment of leptospirosis: queries and projections.

2006

Although the global burden of leptospirosis remains enormous and new aspects of the disease are constantly recognised, little progress has been achieved in the field of leptospirosis therapeutics and queries regarding the utility of antibiotics in the late severe form of the disease remain. From the currently existing data, conclusions on the efficacy of antibiotic administration in severe or late disease cannot easily be drawn, since clinical trials have different selection criteria and may focus on Leptospira serovars with different virulence. However, as a rule the benefit of the doubt should apply. Moreover, new options, such as ceftriaxone, have a superior safety profile to penicillin.…

Microbiology (medical)medicine.medical_specialtymedicine.drug_classAntibioticsDiseaseLeptospirosiMiceLeptospiramedicineAnimalsHumansPharmacology (medical)LeptospirosisIntensive care medicineAntibacterial agentLeptospirabiologybusiness.industryOptimal treatmentCeftriaxoneGeneral Medicinemedicine.diseasebiology.organism_classificationPenicillinLeptospirosisAnti-Bacterial AgentsClinical trialTreatmentSafety profileInfectious DiseasesDoxycyclineImmunologybusinessInternational journal of antimicrobial agents
researchProduct

Establishing a diagnostic tool for assessing optimal treatment timing in Indian children with developing malocclusions

2011

Objective: To interrelate chronological age, cervical vertebrae maturational stage and dental calcification stages and to establish latter as first level diagnostic tool to estimate timing of pubertal growth spurt. Materials and Methods: Sample derived from pretreatment panaromic and lateral cephalometric radiographs of patients 8-14 years old. Study sample divided into three groups depending upon Angle’s molar relation: Group I, Group II, Group III. According to chronological age, into: Group A: 8-11 years Group B:11-14 years, further separating males and female subjects in each group. Demirjian et al method was used to assess dental maturity and for skeletal maturity the New Improved Vers…

Molarbusiness.industryOptimal treatmentDentistryBone ageOdontologíaMandibular first premolar:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludMandibular second molarmedicine.anatomical_structureStatistical significanceUNESCO::CIENCIAS MÉDICASmedicineChi-square testbusinessGeneral DentistryCervical vertebrae
researchProduct

An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance System

2020

The prevalence of diabetes mellitus (DM) rises constantly each year worldwide. Because of that, the funds allocated for the DM treatment have increased over time. Regarding the number of DM cases, Romania is among the top ten countries in Europe. Based on the National Diabetes Programme (NDP), antidiabetic drugs and other expenditures (Self-monitoring blood glucose (SMBG) test, HbA1c, insulin pumps/insulin pumps supplies) are free of charge. This programme has undergone many changes in drugs supply, in the last two decades: re-organizing the NDP, authorization of new molecules with high prices (e.g., SGLT-2 inhibitors, etc.) or new devices (e.g., insulin pumps, etc.) The main purpose of thi…

National Health Programsefficiency indicatorsHealth Toxicology and Mutagenesismedicine.medical_treatmentExploratory researchlcsh:Medicinediabetes mellitus costantidiabetic drugs030209 endocrinology & metabolismArticleNational Diabetes Programme03 medical and health sciencesPharmacoeconomics0302 clinical medicineCost of IllnesspharmacoeconomicsInflation rateDiabetes mellitusHumansMedicine030212 general & internal medicinephysical indicatorsRetrospective StudiesRomaniabusiness.industryOptimal treatmentInsulinlcsh:RPublic Health Environmental and Occupational Healthmedicine.diseaseEuropeDiabetes Mellitus Type 2National health insuranceRomanian National Health Insurance SystemDiabetic patientbusinessDemographyInternational Journal of Environmental Research and Public Health
researchProduct

Rethinking Dual Disorders/Pathology

2013

Objective:Comorbidity of addictive disorders and other psychiatric disorders is very common. The optimal treatment of patients with addiction disorders requires awareness of their comorbid mental disorders and vice versa. The operational and contextual definitions of the different terms used vary si

Pathologymedicine.medical_specialtybusiness.industryOptimal treatmentAddictionmedia_common.quotation_subjectMedicine (miscellaneous)DUAL (cognitive architecture)medicine.diseaseComorbidityPsychiatry and Mental healthPsychiatric comorbiditymental disordersMedicinebusinessmedia_commonAddictive Disorders & Their Treatment
researchProduct

Comparative analysis of fibrinolytic properties of Alteplase, Tenecteplase and Urokinase in an in vitro clot model of intracerebral haemorrhage.

2020

Abstract Objective Hematoma lysis with recombinant tissue plasminogen activator (rtPA) has emerged as an alternative therapy for spontaneous intracerebral and intraventricular haemorrhage (ICH and IVH). However, the MISTIE III and CLEAR III trial failed to show significant improvement of favourable outcomes. Besides experimental and clinical trials revealed neurotoxic effects of rtPA. The demand for optimization of fibrinolytic therapy persists. Herein, we used our recently devised clot model of ICH to systematically analyse fibrinolytic properties of rtPA, tenecteplase and urokinase. Methods In vitro clots of human blood (size: 25 ml and 50 ml; age: 1.5 tenecteplase, 24 tenecteplase and 48…

Time FactorsTenecteplase03 medical and health sciences0302 clinical medicineHematomaFibrinolytic AgentsmedicineHumansThrombolytic TherapyCerebral HemorrhageUrokinaseHuman bloodDose-Response Relationship Drugbusiness.industryOptimal treatmentFibrinolysisRehabilitationmedicine.diseaseUrokinase-Type Plasminogen ActivatorIn vitroCatheterAnesthesiaTissue Plasminogen ActivatorTenecteplaseSurgeryNeurology (clinical)Fibrinolytic therapyCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgerymedicine.drugJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct